Article
Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery
9 May 2020
Abstract excerpt
Inhibitors targeting the general RNA polymerase II (RNAPII) transcription machinery are candidate therapeutics in cancer and other complex diseases. Here, we review the molecular targets and mechanisms of action of these compounds, framing them within the steps of RNAPII transcription. We discuss the effects of transcription inhibitors in vitro and in cellular models (with an emphasis on cancer), as well as their...
Topics
Join the communities discussing this publication.